Evidence map›Paper›PMID 38345668›Full record

SynthesisHernia : the journal of hernias and abdominal wall surgery2024

Ventral hernia repair using bioresorbable poly-4-hydroxybutyrate mesh in clean and contaminated surgical fields: a systematic review and meta-analysis.

A Ahmed, S Gandhi, S Ganam, A-R F Diab, R Mhaskar, J Sujka, C DuCoin, S Docimo

Abstract readMeta-AnalysisSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Hernia : the journal of hernias and abdominal wall surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Ventral hernia is a chronic disease: a systematic review of long-term outcomes beyond 5 years.Hernia : the journal of hernias and abdominal wall surgery · 2025
    Pooled it
  5. Pooled it
  6. Review
  7. Article
  8. Mesh removal and ventral hernia repair with long-term absorbable mesh in case of mesh infection.Hernia : the journal of hernias and abdominal wall surgery · 2025
    Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

A AhmedUniversity of South Florida Morsani College of Medicine, Tampa, FL, USA.
S GandhiUniversity of South Florida Morsani College of Medicine, Tampa, FL, USA.
S GanamUniversity of South Florida Morsani College of Medicine, Tampa, FL, USA.
A-R F DiabUniversity of South Florida Morsani College of Medicine, Tampa, FL, USA.
R MhaskarUniversity of South Florida Morsani College of Medicine, Tampa, FL, USA.
J SujkaUniversity of South Florida Morsani College of Medicine, Tampa, FL, USA.
C DuCoinUniversity of South Florida Morsani College of Medicine, Tampa, FL, USA.
S DocimoUniversity of South Florida Morsani College of Medicine, Tampa, FL, USA. docimo@usf.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeUse of biologic or synthetic mesh in hernia repair shifts is based on evolving evidence. Poly-4-hydroxybutyrate (P4HB) biosynthetic mesh is a potential alternative to biologic and synthetic mesh in ventral hernia repair (VHR). This meta-analysis assesses the efficacy of P4HB mesh in clean and contaminated surgical settings.

methodsTwo authors searched literature on PubMed, reviewing titles and abstracts of all articles to determine inclusion eligibility. Post-operative data were compared via transformation method to convert the proportion of patients with the outcome of interest into a suitable quantity for random-effects synthesis using STATA software.

resultsInitial search yielded 287 citations. Six studies were included and categorized on whether hernia repairs were conducted in clean (CDC class I) or contaminated cases (CDC class II-IV). The pooled proportion of surgical site infection (SSI), surgical site occurrence (SSO), hernia recurrence, total surgical complications, and reoperation were calculated in 391 clean and 81 contaminated cases. For clean vs. contaminated cases, the following pooled proportions were noted: SSI (2% (CI 0-7%) vs 9% (CI 0-025) (p = 0.03), SSO: 14% (CI 5-25%) vs 35% (CI 22-50%) (p = 0.006), hernia recurrence (8% (CI 1-19%) vs 4% (CI 0-12%) (p = 0.769); surgical complications (17% (CI 6-32%) vs 50% (CI 27-72%) (p = 0.009). Reoperation data were available in 298 clean cases across four studies: 5% (CI 0-15%).

conclusionsP4HB biosynthetic mesh may be more effective than previously thought, particularly in clean wounds. P4HB may also be superior to biologic mesh when compared to clinical trial data. Further research is necessary for more direct comparison.

Indexed as

Biological ProductsHernia, VentralAbsorbable ImplantsHerniorrhaphyHumansHydroxybutyratesRecurrenceRetrospective StudiesSurgical MeshSurgical Wound InfectionTreatment OutcomeBiological ProductsHydroxybutyratesBiosynthetic meshMeta-analysisP4HBVentral hernia repair

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.